Musib L - Search Results

1

Mass Balance, Metabolic Pathways, Absolute Bioavailability, and Pharmacokinetics of Giredestrant in Healthy Subjects.

Kshirsagar S, Chen YC, Yu J, Gates MR, Kawakatsu S, Khojasteh SC, Ma S, Musib L, Malhi V, Osaghae U, Wang J, Cho S, Tang YT, Zhang D, Zhao W, De Bruyn T. Kshirsagar S, et al. Among authors: musib l. Drug Metab Dispos. 2024 Jul 16;52(8):847-857. doi: 10.1124/dmd.124.001688. Drug Metab Dispos. 2024. PMID: 38834357

2

Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans.

Takahashi RH, Choo EF, Ma S, Wong S, Halladay J, Deng Y, Rooney I, Gates M, Hop CE, Khojasteh SC, Dresser MJ, Musib L. Takahashi RH, et al. Among authors: musib l. Drug Metab Dispos. 2016 Jan;44(1):28-39. doi: 10.1124/dmd.115.066282. Epub 2015 Oct 8. Drug Metab Dispos. 2016. PMID: 26451002 Clinical Trial.

3

The Absolute Bioavailability and Absorption, Metabolism, and Excretion of Ipatasertib, a Potent and Highly Selective Protein Kinase B (Akt) Inhibitor.

Takahashi RH, Malhi V, Liederer BM, Cho S, Deng Y, Dean B, Nugteren J, Yost E, Al-Sayah MA, Sane R, Kshirsagar S, Ma S, Musib L. Takahashi RH, et al. Among authors: musib l. Drug Metab Dispos. 2023 Oct;51(10):1332-1341. doi: 10.1124/dmd.122.001175. Epub 2023 Jul 31. Drug Metab Dispos. 2023. PMID: 37524543

4

Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic Function.

Sane R, Malhi V, Sutaria DS, Cho E, Twomey P, Craggs C, Wang J, Harris A, Musib L. Sane R, et al. Among authors: musib l. J Clin Pharmacol. 2022 Feb;62(2):171-181. doi: 10.1002/jcph.1941. Epub 2021 Dec 23. J Clin Pharmacol. 2022. PMID: 34402068 Free PMC article. Clinical Trial.

5

Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib.

Malhi V, Budha N, Sane R, Huang J, Liederer B, Meng R, Patel P, Deng Y, Cervantes A, Tabernero J, Musib L. Malhi V, et al. Among authors: musib l. Cancer Chemother Pharmacol. 2021 Dec;88(6):921-930. doi: 10.1007/s00280-021-04344-9. Epub 2021 Sep 1. Cancer Chemother Pharmacol. 2021. PMID: 34471960 Clinical Trial.

6

Evaluation of Ipatasertib Interactions with Itraconazole and Coproporphyrin I and III in a Single Drug Interaction Study in Healthy Subjects.

Sane RS, Cheung KWK, Cho E, Liederer BM, Hanover J, Malhi V, Plise E, Wong S, Musib L. Sane RS, et al. Among authors: musib l. J Pharmacol Exp Ther. 2021 Aug;378(2):87-95. doi: 10.1124/jpet.121.000620. Epub 2021 May 28. J Pharmacol Exp Ther. 2021. PMID: 34049965 Clinical Trial.

7

Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.

Cheeti S, Hou HH, Nelson E, Walker H, Chen B, Morley R, Gates M, Musib L, Girish S, Sahasranaman S, Liu L. Cheeti S, et al. Among authors: musib l. Pharm Res. 2018 Oct 15;35(12):233. doi: 10.1007/s11095-018-2516-0. Pharm Res. 2018. PMID: 30324422 Free PMC article. Clinical Trial.

8

Correction to: Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.

Cheeti S, Hou HH, Nelson E, Walker H, Chen B, Morley R, Gates M, Musib L, Girish S, Sahasranaman S, Liu L. Cheeti S, et al. Among authors: musib l. Pharm Res. 2018 Oct 26;35(12):244. doi: 10.1007/s11095-018-2529-8. Pharm Res. 2018. PMID: 30367284 Free PMC article.

9

Calibrating the In Vitro-In Vivo Correlation for OATP-Mediated Drug-Drug Interactions with Rosuvastatin Using Static and PBPK Models.

Sane R, Cheung KWK, Kovács P, Farasyn T, Li R, Bui A, Musib L, Kis E, Plise E, Gáborik Z. Sane R, et al. Among authors: musib l. Drug Metab Dispos. 2020 Dec;48(12):1264-1270. doi: 10.1124/dmd.120.000149. Epub 2020 Oct 9. Drug Metab Dispos. 2020. PMID: 33037044

10

Absolute bioavailability and effect of formulation change, food, or elevated pH with rabeprazole on cobimetinib absorption in healthy subjects.

Musib L, Choo E, Deng Y, Eppler S, Rooney I, Chan IT, Dresser MJ. Musib L, et al. Mol Pharm. 2013 Nov 4;10(11):4046-54. doi: 10.1021/mp400383x. Epub 2013 Sep 30. Mol Pharm. 2013. PMID: 24010577 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters